These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2097150)

  • 21. Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites.
    Wefers C; Duiveman-de Boer T; Yigit R; Zusterzeel PLM; van Altena AM; Massuger LFAG; De Vries IJM
    Front Immunol; 2018; 9():3156. PubMed ID: 30687337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intracavitary administration of recombinant interferon in cancer patients with malignant effusions].
    Takashima S; Saeki T; Saeki H; Tanada M; Takiyama W; Kimura T; Moriwaki S
    Gan No Rinsho; 1986 Sep; 32(11):1451-7. PubMed ID: 3773273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Various immunological and immunomorphological changes in patients with breast cancer after interferon administration].
    Mkrtchian LN; Galstian AM; Ovanesbekova TG; Ter-Pogosian ZR; Kuznetsov VP
    Vopr Onkol; 1986; 32(10):25-31. PubMed ID: 3490716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation.
    Fattorossi A; Battaglia A; Pierelli L; Malinconico P; Andreocci L; Perillo A; Ferrandina G; Martelli O; Rughetti A; Nuti M; Cortesi E; Scambia G
    Cancer Immunol Immunother; 2001 Feb; 49(12):641-8. PubMed ID: 11258790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine.
    Sandmaier BM; Oparin DV; Holmberg LA; Reddish MA; MacLean GD; Longenecker BM
    J Immunother; 1999 Jan; 22(1):54-66. PubMed ID: 9924700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term clinical and immunological effects of p53-SLP® vaccine in patients with ovarian cancer.
    Leffers N; Vermeij R; Hoogeboom BN; Schulze UR; Wolf R; Hamming IE; van der Zee AG; Melief KJ; van der Burg SH; Daemen T; Nijman HW
    Int J Cancer; 2012 Jan; 130(1):105-12. PubMed ID: 21328579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of immunotherapy and hyperthermia on advanced or recurrent ovarian and uterine cancer - 229 clinical cases].
    Nakamura K; Hanazawa S; Takeda T; Sumiyoshi R; Kobayashi S; Takeda H; Takeda T
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1295-7. PubMed ID: 25335722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Locoregional ascites therapy with cytostatic drugs and immune modulators in gynecologic neoplasms].
    Werner A; Mallmann P; Chronides A; Diedrich K; Wagner U; Krebs D
    Zentralbl Gynakol; 1991; 113(23):1313-22. PubMed ID: 1796665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of lymphocyte subsets in the peripheral blood of patients with malignant ovarian tumors].
    Liu M; Xie J; Zhao S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):627-9, 634. PubMed ID: 24909286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [T- and B-lymphocytes and the A, M and G immunoglobulins in women with malignant neoplasms of the genital organs].
    Blicharski J; Bodzoń A; Lisiewicz J; Paruch J; Piotrowski J
    Ginekol Pol; 1980 May; 51(5):389-94. PubMed ID: 6967845
    [No Abstract]   [Full Text] [Related]  

  • 31. Intraperitoneal alpha interferon for ovarian cancer: a case report.
    Carney-Gersten P; Moore MD; Giuffre M
    Oncol Nurs Forum; 1990; 17(3):403-7. PubMed ID: 2342974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma.
    Raspollini MR; Castiglione F; Rossi Degl'innocenti D; Amunni G; Villanucci A; Garbini F; Baroni G; Taddei GL
    Ann Oncol; 2005 Apr; 16(4):590-6. PubMed ID: 15699022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T8 and T3 surface glycoproteins in human T-cell mediation of leukocyte adherence inhibition to extracts of autologous cancer.
    Labateya N; Thomson DM
    J Natl Cancer Inst; 1985 Dec; 75(6):987-94. PubMed ID: 2999497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD80-transfected human breast and ovarian tumor cell lines: improved immunogenicity and induction of cytolytic CD8+ T lymphocytes.
    Gückel B; Lindauer M; Rudy W; Habicht A; Siebels M; Kaul S; Bastert G; Meuer SC; Moebius U
    Cytokines Mol Ther; 1995 Sep; 1(3):211-21. PubMed ID: 9384677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
    Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
    Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.
    Whiteside TL; Miescher S; Hurlimann J; Moretta L; von Fliedner V
    Cancer Immunol Immunother; 1986; 23(3):169-78. PubMed ID: 3024832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
    Wang P; Vánky F; Klein E
    Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The assessment of cellular immunity parameters in patients with breast cancer and lymphogranulomatosis during dynamic treatment].
    Baldueva IA; Pukhova ZhK; Gavrilenkova LP; Mosberger ID
    Vopr Onkol; 1992; 38(7):787-92. PubMed ID: 1300783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.